Results 251 to 260 of about 775,018 (304)

Spontaneous Regression of Metastatic Colorectal Cancer Following Discontinuation of an Interleukin-6 Receptor Inhibitor: A Case Report. [PDF]

open access: yesSurg Case Rep
Miyake E   +12 more
europepmc   +1 more source

Measurement of Interleukin 6

Current Protocols in Immunology, 1996
AbstractInterleukin 6 (IL‐6) is a pluripotent cytokine with multiple effects on many different cell types. It is produced by a variety of cells in response to immunological and other stimuli. This unit describes a simple and sensitive assay for human, rat, rabbit, pig, and mouse IL‐6, based on IL‐6‐dependent proliferation of a murine B cell hybridoma ...
R P, Nordan, C D, Richards, J, Gauldie
openaire   +2 more sources

Exercise and interleukin-6

Current Opinion in Hematology, 2001
Strenuous exercise induces increased levels in a number of pro-and anti-inflammatory cytokines, natural occurring cytokine inhibitors, and chemokines. Thus, increased plasma levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, IL-1 receptor antagonist (IL-1ra), TNF-receptors (TNF-R), IL-10, IL-8, and macrophage inflammatory protein ...
B K, Pedersen   +2 more
openaire   +2 more sources

Interleukin-6 and melanoma

Melanoma Research, 2012
Interleukin-6 (IL-6) is a pleiotropic immunomodulatory cytokine produced by various types of cells, including melanoma cells. IL-6 plays a major role in the pathogenesis and development of malignancies. It promotes tumour growth by inhibition of apoptosis and induces tumour angiogenesis. IL-6 is deregulated in many types of cancers, and increased serum
Hoejberg, Lise   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy